ID PUR8_STAHJ Reviewed; 431 AA. AC Q4L7M3; DT 14-NOV-2006, integrated into UniProtKB/Swiss-Prot. DT 02-AUG-2005, sequence version 1. DT 16-JUN-2009, entry version 35. DE RecName: Full=Adenylosuccinate lyase; DE Short=ASL; DE EC=4.3.2.2; DE AltName: Full=Adenylosuccinase; DE Short=ASase; GN Name=purB; OrderedLocusNames=SH1043; OS Staphylococcus haemolyticus (strain JCSC1435). OC Bacteria; Firmicutes; Bacillales; Staphylococcus. OX NCBI_TaxID=279808; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16237012; DOI=10.1128/JB.187.21.7292-7308.2005; RA Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y., RA Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S., RA Lee J.C., Hiramatsu K.; RT "Whole-genome sequencing of Staphylococcus haemolyticus uncovers the RT extreme plasticity of its genome and the evolution of human-colonizing RT staphylococcal species."; RL J. Bacteriol. 187:7292-7308(2005). CC -!- CATALYTIC ACTIVITY: N(6)-(1,2-dicarboxyethyl)AMP = fumarate + AMP. CC -!- CATALYTIC ACTIVITY: (S)-2-(5-amino-1-(5-phospho-D- CC ribosyl)imidazole-4-carboxamido)succinate = fumarate + 5-amino-1- CC (5-phospho-D-ribosyl)imidazole-4-carboxamide. CC -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway; CC AMP from IMP: step 2/2. CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; CC 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from N(2)- CC formyl-N(1)-(5-phospho-D-ribosyl)glycinamide: step 5/5. CC -!- SIMILARITY: Belongs to the lyase 1 family. Adenylosuccinate lyase CC subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AP006716; BAE04352.1; -; Genomic_DNA. DR RefSeq; YP_252958.1; -. DR SMR; Q4L7M3; 2-430. DR GeneID; 3481954; -. DR GenomeReviews; AP006716_GR; SH1043. DR KEGG; sha:SH1043; -. DR NMPDR; fig|279808.3.peg.1757; -. DR HOGENOM; Q4L7M3; -. DR OMA; Q4L7M3; HPIDFRY. DR BioCyc; SHAE279808:SH1043-MON; -. DR GO; GO:0070626; F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imida...; IEA:EC. DR GO; GO:0004018; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumar...; IEA:EC. DR GO; GO:0009152; P:purine ribonucleotide biosynthetic process; IEA:InterPro. DR InterPro; IPR019468; Adenylosuccinate_lyase_C. DR InterPro; IPR003031; D_crystallin. DR InterPro; IPR000362; Fumarate_lyase. DR InterPro; IPR004769; Pur_lyase. DR Pfam; PF10397; ADSL_C; 1. DR Pfam; PF00206; Lyase_1; 1. DR PRINTS; PR00145; DCRYSTALLIN. DR PRINTS; PR00149; FUMRATELYASE. DR TIGRFAMs; TIGR00928; purB; 1. DR PROSITE; PS00163; FUMARATE_LYASES; 1. PE 3: Inferred from homology; KW Complete proteome; Lyase; Purine biosynthesis. FT CHAIN 1 431 Adenylosuccinate lyase. FT /FTId=PRO_0000259984. FT ACT_SITE 68 68 Proton donor (By similarity). FT ACT_SITE 141 141 Proton acceptor (By similarity). SQ SEQUENCE 431 AA; 49894 MW; 88C7A78DF1E97747 CRC64; MIDRYSREEM ANIWTDQNRY EAWLEVEILA CEAWSELGHI PKEDVKKIRQ NAKVDVKRAQ EIEQETRHDV VAFTRQVSET LGDERKWVHY GLTSTDVVDT ALSYVIKQAN EIIEKDIERF IKVLEEKAKN YKYTLMMGRT HGVHAEPTTF GVKMALWYTE MKRNLKRFKE VRKEIEVGKM SGAVGTFANI PPEIEQYVCD HLGIDTASVS TQTLQRDRHA YYIATLALVA TSLEKFAVEI RNLQKTETRE VEEAFAKGQK GSSAMPHKRN PIGSENITGI SRVIRGYITT AYENVPLWHE RDISHSSAER IMLPDVTIAL DYALNRFTNI VDRLTVFEDN MRNNIDKTFG LIFSQRVLLA LINKGMVREE AYDRVQPKAM ESWETKTPFR QLIEKDESIT NVLSKEELDE CFNPEHHLNQ VDTIFKRAGL E //